Waters Corporation (WAT)
Waters Corporation (WAT) carries a ŷRobot AI score of 56 out of 100. The model's fair value estimate is $419.77, 3.9% below the last close of $436.69. The chart signal reads Sell.
| Metric | WAT |
|---|---|
| AI score | 56 / 100 |
| Chart signal | Sell |
| Fair value estimate | $419.77 |
| Upside to fair value | -3.9% |
| Previous close | $436.69 |
| P/E | 111.10 |
| Price / sales | 9.00 |
| Market cap | $42.43B |
| EPS | 3.83 |
| Revenue growth | 1.9% |
| 1-year price change | 5.4% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, Merck & Company Inc, UnitedHealth Group Incorporated, Novartis AG ADR.
Questions about WAT
Is WAT overvalued or undervalued right now?
As of Oct 14, 2026, ŷRobot's fair-value model estimates Waters Corporation (WAT) at $419.77 against a last close of $436.69, implying 3.9% downside to the model's estimate.
Is WAT's chart signal bullish or bearish?
The chart-signal model classifies WAT as Neutral as of Oct 14, 2026, with a signal score of -0.12 on a -1 to 1 scale.
What is WAT's ŷRobot AI score?
WAT scores 56 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Oct 14, 2026.
Is WAT stock expensive on P/E and P/S?
WAT trades at 111.1 times earnings and 9.0 times sales as of Oct 14, 2026.
What does WAT's seasonal forecast show?
ŷRobot's seasonal forecast curve for WAT reads +2.9% at 30 days, +9.4% at 90 days, and +5.4% at one year as of Oct 14, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is WAT growing?
Waters Corporation's revenue growth is +1.9% and free-cash-flow growth is -8.4% on the latest reported figures.
WAT chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.